SIM
CPXX

Spark Investment Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Spark Investment Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-35,450
Closed -$86K – 818
2015
Q1 		$86K Sell
35,450
-6,050
-15% -$16.3K 0.01% 635
2014
Q4 		$80K Buy
41,500
+21,600
+109% +$44.8K 0.01% 601
2014
Q3 		$49K Buy
19,900
+9,400
+90% +$25.7K 0.01% 638
2014
Q2 		$31K Buy
+10,500
New +$28.9K ﹤0.01% 616

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Spark Investment Management's CPXX Position: Q2 2015 in Review

Spark Investment Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q2 2015, closing a stake of 35,450 shares — an estimated $86K sold.

Spark Investment Management first reported a position in CPXX in Q2 2014 and held it in 4 quarters. The position peaked at $86K in Q1 2015. 16 funds tracked by Wall St. Rank hold CPXX as of Q2 2015.

  • Spark Investment Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 35,450 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q2 2015, an estimated $86K.
  • Spark Investment Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2014 and held it in 4 quarters.
  • Spark Investment Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $86K in Q1 2015.
  • 16 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.